159 related articles for article (PubMed ID: 21896167)
41. Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail.
Côté M; Zheng YM; Liu SL
PLoS One; 2012; 7(3):e33734. PubMed ID: 22479434
[TBL] [Abstract][Full Text] [Related]
42. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.
Silverman RH; Nguyen C; Weight CJ; Klein EA
Nat Rev Urol; 2010 Jul; 7(7):392-402. PubMed ID: 20517289
[TBL] [Abstract][Full Text] [Related]
43. Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.
Curriu M; Carrillo J; Massanella M; Garcia E; Cunyat F; Peña R; Wienberg P; Carrato C; Areal J; Bofill M; Clotet B; Blanco J; Cabrera C
PLoS One; 2012; 7(5):e37415. PubMed ID: 22616002
[TBL] [Abstract][Full Text] [Related]
44. Recombinant origin of the retrovirus XMRV.
Paprotka T; Delviks-Frankenberry KA; Cingöz O; Martinez A; Kung HJ; Tepper CG; Hu WS; Fivash MJ; Coffin JM; Pathak VK
Science; 2011 Jul; 333(6038):97-101. PubMed ID: 21628392
[TBL] [Abstract][Full Text] [Related]
45. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?
Stieler K; Schumacher U; Horst AK; Fischer N
PLoS One; 2012; 7(7):e42321. PubMed ID: 22848758
[TBL] [Abstract][Full Text] [Related]
46. Quantitative evaluation of HIV-1 coreceptor use in the GHOST3 cell assay.
Vödrös D; Tscherning-Casper C; Navea L; Schols D; De Clercq E; Fenyö EM
Virology; 2001 Dec; 291(1):1-11. PubMed ID: 11878871
[TBL] [Abstract][Full Text] [Related]
47. Absence of XMRV retrovirus and other murine leukemia virus-related viruses in patients with chronic fatigue syndrome.
Shin CH; Bateman L; Schlaberg R; Bunker AM; Leonard CJ; Hughen RW; Light AR; Light KC; Singh IR
J Virol; 2011 Jul; 85(14):7195-202. PubMed ID: 21543496
[TBL] [Abstract][Full Text] [Related]
48. Xenotropic murine leukemia virus-related virus-associated chronic fatigue syndrome reveals a distinct inflammatory signature.
Lombardi VC; Hagen KS; Hunter KW; Diamond JW; Smith-Gagen J; Yang W; Mikovits JA
In Vivo; 2011; 25(3):307-14. PubMed ID: 21576403
[TBL] [Abstract][Full Text] [Related]
49. Restricted replication of xenotropic murine leukemia virus-related virus in pigtailed macaques.
Del Prete GQ; Kearney MF; Spindler J; Wiegand A; Chertova E; Roser JD; Estes JD; Hao XP; Trubey CM; Lara A; Lee K; Chaipan C; Bess JW; Nagashima K; Keele BF; Macallister R; Smedley J; Pathak VK; Kewalramani VN; Coffin JM; Lifson JD
J Virol; 2012 Mar; 86(6):3152-66. PubMed ID: 22238316
[TBL] [Abstract][Full Text] [Related]
50. In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer.
Lee D; Das Gupta J; Gaughan C; Steffen I; Tang N; Luk KC; Qiu X; Urisman A; Fischer N; Molinaro R; Broz M; Schochetman G; Klein EA; Ganem D; Derisi JL; Simmons G; Hackett J; Silverman RH; Chiu CY
PLoS One; 2012; 7(9):e44954. PubMed ID: 23028701
[TBL] [Abstract][Full Text] [Related]
51. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Mörner A; Björndal A; Albert J; Kewalramani VN; Littman DR; Inoue R; Thorstensson R; Fenyö EM; Björling E
J Virol; 1999 Mar; 73(3):2343-9. PubMed ID: 9971817
[TBL] [Abstract][Full Text] [Related]
52. Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.
Murgai M; Thomas J; Cherepanova O; Delviks-Frankenberry K; Deeble P; Pathak VK; Rekosh D; Owens G
Retrovirology; 2013 Mar; 10():34. PubMed ID: 23537062
[TBL] [Abstract][Full Text] [Related]
53. Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients.
Maggi F; Focosi D; Lanini L; Sbranti S; Mazzetti P; Macera L; Davini S; De Donno M; Mariotti ML; Antonelli G; Scatena F; Pistello M
Clin Microbiol Infect; 2012 Feb; 18(2):184-8. PubMed ID: 21672082
[TBL] [Abstract][Full Text] [Related]
54. XMRV, prostate cancer and chronic fatigue syndrome.
Kenyon JC; Lever AM
Br Med Bull; 2011; 98():61-74. PubMed ID: 21551158
[TBL] [Abstract][Full Text] [Related]
55. No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients.
Mendoza R; Silverman RH; Klein EA; Miller AD
PLoS One; 2012; 7(5):e36073. PubMed ID: 22615749
[TBL] [Abstract][Full Text] [Related]
56. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses.
Smith RA
Retrovirology; 2010 Dec; 7():112. PubMed ID: 21171980
[TBL] [Abstract][Full Text] [Related]
57. Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer.
Kim S; Kim N; Dong B; Boren D; Lee SA; Das Gupta J; Gaughan C; Klein EA; Lee C; Silverman RH; Chow SA
J Virol; 2008 Oct; 82(20):9964-77. PubMed ID: 18684813
[TBL] [Abstract][Full Text] [Related]
58. Murine gammaretrovirus group G3 was not found in Swedish patients with myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia.
Elfaitouri A; Shao X; Mattsson Ulfstedt J; Muradrasoli S; Bölin Wiener A; Golbob S; Ohrmalm C; Matousek M; Zachrisson O; Gottfries CG; Blomberg J
PLoS One; 2011; 6(10):e24602. PubMed ID: 22022360
[TBL] [Abstract][Full Text] [Related]
59. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection.
Garson JA; Kellam P; Towers GJ
Retrovirology; 2011 Feb; 8():13. PubMed ID: 21352548
[TBL] [Abstract][Full Text] [Related]
60. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
